Skip to main content

Table 5 Cumulative adverse events

From: Comparison of intraoperative handling and wound healing between (NEOSORB® plus) and coated polyglactin 910 suture (NEOSORB®): a prospective, single-blind, randomized controlled trial

 

Adverse events, n, (%)

Any

Serious

Requiring surgery

Device-related

Open surgery

aNP (n = 23)

2 (8.7)

0

0

0

bN (n = 25)

3 (12.0)

2 (8.0)

1 (4.0)

0

Minimally invasive surgery

NP (n = 24)

2 (8.3)

1 (4.2)

1 (4.2)

0

N (n = 24)

0

0

0

0

All patients

N (n = 96)

7 (7.3)

3 (3.1)

2 (2.1)

0

  1. aNP, NEOSORB® Plus; bN, NEOSORB®
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us